| BALCX | SCORX | BALCX / SCORX | |
| Total Expense Ratio | 1.30 | 0.75 | 173% |
| Annual Report Gross Expense Ratio | 1.30 | 0.84 | 155% |
| Fund Existence | 26 years | 19 years | - |
| Gain YTD | 7.959 | 6.911 | 115% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 285B | 43.2M | 659,722% |
| Annual Yield % from dividends | 1.14 | 1.43 | 80% |
| Returns for 1 year | 5.86 | 7.25 | 81% |
| Returns for 3 years | 38.31 | 38.03 | 101% |
| Returns for 5 years | 27.49 | 32.38 | 85% |
| Returns for 10 years | 75.19 | 84.23 | 89% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NBPIX | 62.58 | 0.39 | +0.63% |
| Neuberger Large Cap Value Instl | |||
| PPNPX | 15.31 | N/A | N/A |
| Principal SmallCap Growth I R5 | |||
| CWSIX | 14.80 | N/A | N/A |
| Carillon Chartwell Small Cap Value I | |||
| DTLGX | 43.74 | N/A | N/A |
| Wilshire Large Company Growth Invmt | |||
| RMQAX | 621.44 | N/A | N/A |
| Rydex Monthly Rbl NASDAQ-100® 2x Strt A | |||